verified SJR 11,729 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Neurology (clinical) lock_open Open Access

The Lancet Neurology

The Lancet Neurology is a journal indexed in SJR in Neurology (clinical) with an H index of 379. It has an SJR impact factor of 11,729 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 11,729.

The Lancet Neurology focuses its scope in these topics and keywords: disease, disorders, diagnosis, multiple, patients, sporadic, cerebral, traumatic, reality, brain, ...

ISSN: 1474-4422

Publisher: Elsevier Ltd

Category: Neurology (clinical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

11,729 Q1

H-index 379

Acceptance rate pie_chart

17% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

11,729

H-index

379

Docs (year)

326

Docs 3y

809

Total refs

5398

Cites 3y

9796

Citable 3y

288

Cites/Doc 2y

10.2

Ref/Doc

16.56

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cancer stem cells may drive growth of paediatric brain tumours

Yeast studies provide clues to neurodegeneration

Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis

Determining death

Cytokines in sudden infant death syndrome

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis

cPLA2: common link in the pathogenesis of multiple sclerosis

Cost-benefit analysis for epilepsy surgery

Cocaine use may damage dopaminergic system

Clazosentan for patients with subarachnoid haemorrhage: lessons learned -Authors' reply

Clazosentan for patients with subarachnoid haemorrhage: lessons learned

Chris Polman: quietly making multiple sclerosis research tick

SHOW MORE ARTICLES

Caring about caring

A child's eye view

Breaking the diagnosis of dementia

Brain Imaging in Epilepsy

Antiprogesterone hope for inherited neuropathy

Anticysticercal treatment and seizures in neurocysticercosis

Alcoholism damages the brain, but does moderate alcohol use?

AIDS and stroke risk

Adult neural stem cells localised in SVZ

Acetylcholine and memory formation

A Wellcome relief

A spoonful of trehalose makes the protein aggregations go down

FAQs

The Lancet Neurology has an SJR of 11,729 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for The Lancet Neurology is 17%.

The Lancet Neurology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of The Lancet Neurology?

What is the APC / publication cost?

What is the acceptance rate?